A second blood test has been been approved by the US Food and Drug Administration to assist in diagnosing Alzheimer’s disease ...

Test your observation skills with a social media hit \"spot the difference\" puzzle featuring a grandmother and granddaughter ...

We know of Alzheimer’s as a progressive disease, with the first subtle indications emerging up to 18 years before people ...

Increasing use of social media throughout early adolescence is associated with lower performance in specific aspects of cognitive function.

The FDA has granted 510(k) clearance to a blood-based biomarker test indicated for early detection of Alzheimer’s disease and other causes of cognitive decline within a primary care setting, according ...

Both low and high increases in use were negatively but weakly associated with adolescent cognitive performance 2 years later.

The U.S. Food and Drug Administration (FDA) has cleared another blood test that could help doctors identify whether a patient ...

The test—developed in collaboration with Eli Lilly and Co.—does not diagnose Alzheimer’s but is designed to rule out the ...

Quitting smoking during midlife or even later on can help slow down age-related cognitive decline, a new study suggests ...